pSIN-PAmCherry-KFERQ-NE Citations (3)

Originally described in: Age-dependent accumulation of oligomeric SNCA/alpha-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA).
Ho PW, Leung CT, Liu H, Pang SY, Lam CS, Xian J, Li L, Kung MH, Ramsden DB, Ho SL Autophagy. 2019 Apr 14:1-24. doi: 10.1080/15548627.2019.1603545. PubMed Journal

---

Articles Citing pSIN-PAmCherry-KFERQ-NE

Articles
SNX10-mediated degradation of LAMP2A by NSAIDs inhibits chaperone-mediated autophagy and induces hepatic lipid accumulation. Lee W, Kim HY, Choi YJ, Jung SH, Nam YA, Zhang Y, Yun SH, Chang TS, Lee BH. Theranostics. 2022 Feb 21;12(5):2351-2369. doi: 10.7150/thno.70692. eCollection 2022. PubMed
Manassantin A inhibits tumour growth under hypoxia through the activation of chaperone-mediated autophagy by modulating Hsp90 activity. Byun JK, Lee SH, Moon EJ, Park MH, Jang H, Weitzel DH, Kim HH, Basnet N, Kwon DY, Lee CT, Stephenson TN, Jeong JH, Patel BA, Park SJ, Chi JT, Dewhirst MW, Hong J, Lee YM. Br J Cancer. 2023 Apr;128(8):1491-1502. doi: 10.1038/s41416-023-02148-7. Epub 2023 Feb 9. PubMed
ALKBH1 promotes HIF-1alpha-mediated glycolysis by inhibiting N-glycosylation of LAMP2A. Liu Y, Li M, Lin M, Liu X, Guo H, Tan J, Hu L, Li J, Zhou Q. Cell Mol Life Sci. 2024 Mar 12;81(1):130. doi: 10.1007/s00018-024-05152-z. PubMed

If you have published an article using this material, please email us at to have your article added to this page.